deltatrials
Completed OBSERVATIONAL NCT00342537

Genetics of Familial Testicular Cancer

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Studies of Familial Testicular Germ Cell Tumors

Sponsor: National Cancer Institute (NCI)

Updated 24 times since 2017 Last updated: Jul 16, 2020 Started: Jan 2, 2004 Primary completion: Dec 31, 2019 Completion: Jul 14, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Testicular Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 24 recorded versions since 2004 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshot~Sep 2017 – ~Apr 2018 · 7 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Feb 2019 · 3 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Aug 2019 · 3 months · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Dec 2019 · 2 months · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Aug 2020 · 5 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

24 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

Show 19 earlier versions
  1. Aug 2020 — Nov 2020 [monthly]

    Completed

  2. Mar 2020 — Aug 2020 [monthly]

    Completed

  3. Feb 2020 — Mar 2020 [monthly]

    Completed

  4. Jan 2020 — Feb 2020 [monthly]

    Completed

  5. Dec 2019 — Jan 2020 [monthly]

    Completed

  6. Oct 2019 — Dec 2019 [monthly]

    Completed

  7. Aug 2019 — Oct 2019 [monthly]

    Completed

  8. May 2019 — Aug 2019 [monthly]

    Completed

  9. Apr 2019 — May 2019 [monthly]

    Completed

  10. Mar 2019 — Apr 2019 [monthly]

    Completed

  11. Feb 2019 — Mar 2019 [monthly]

    Completed

  12. Nov 2018 — Feb 2019 [monthly]

    Completed

  13. Oct 2018 — Nov 2018 [monthly]

    Completed

  14. Sep 2018 — Oct 2018 [monthly]

    Completed

  15. Jun 2018 — Sep 2018 [monthly]

    Completed

  16. May 2018 — Jun 2018 [monthly]

    Completed

  17. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  18. Sep 2017 — Apr 2018 [monthly]

    Completed NA

  19. Jan 2017 — Sep 2017 [monthly]

    Completed NA

    First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations